Liposeuticals
1 known investors
Find your way into Liposeuticals
Liposeuticals develops proprietary formulations of sterile injectable drugs for hospital use, focusing on anesthesiology, oncology, and infectious disease treatments. The company's sugar-lipid polymer technology platform reformulates water-insoluble compounds to improve stability, shelf life, manufacturability, and patient safety compared to existing emulsion-based approaches.
Investors · 1
Non-dilutive funding · 1 SBIR/STTR award
Federal grants — no equity taken| Agency | Phase | Year | Amount |
|---|---|---|---|
| Department of DefenseDefense Health Program | Phase ISTTR | 2017 | $150K |
Source: SBIR.gov award data (U.S. Small Business Administration). SBIR/STTR awards are competitive federal R&D grants and contracts — non-dilutive capital alongside any venture rounds above.
Frequently asked questions
- What does Liposeuticals do?
- Liposeuticals develops proprietary formulations of sterile injectable drugs for hospital use, focusing on anesthesiology, oncology, and infectious disease treatments. The company's sugar-lipid polymer technology platform reformulates water-insoluble compounds to improve stability, shelf life, manufacturability, and patient safety compared to existing emulsion-based approaches.
- Who are Liposeuticals's investors?
- Liposeuticals's investors include Delos Capital.